Diabetes 50:1949-1951, 2001
© 2001 by the American Diabetes Association, Inc.
New Amino Acid Substitutions in the IRS-2 Gene in Finnish and Chinese Subjects With Late-Onset Type 2 Diabetes
Hua Wang,
Johanna Rissanen,
Raija Miettinen,
Päivi Kärkkäinen,
Päivi Kekäläinen,
Johanna Kuusisto,
Leena Mykkänen,
Pauli Karhapää, and
Markku Laakso
Department of Medicine, University of Kuopio, Kuopio, Finland
We investigated the significance of the variants of the IRS-2 gene in patients with type 2 diabetes. The entire coding part of the IRS-2 gene was screened by single-strand conformation polymorphism analysis in 40 Chinese and 40 Finnish patients with late-onset type 2 diabetes. The association of the variants of the IRS-2 gene with type 2 diabetes was studied in 85 Finnish diabetic patients and 82 Finnish control subjects and in 100 Chinese diabetic patients and 85 Chinese control subjects. The four variants predicting structural changes in the insulin receptor substrate (IRS)-2 protein included an insertion of AAC (Asn) in the Asn repeat sequence centered around codons 2936 (allele frequencies of 0 vs. 0.6% and 1.5 vs. 0%), the Ala157Thr substitution (0 vs. 0% and 0.5 vs. 0%), the Leu647Val substitution (0.6 vs. 0% and 0 vs. 0%), and the Gly1057Asp polymorphism (31 vs. 31% and 35 vs. 30%) (P = NS for all comparisons). Furthermore, six silent variants were observed (CGC147CGG, CCC155CCG, GCC156GCT, AGT723AGC, TGT816TGC, and CCC829CCT). The Gly1057Asp polymorphism was not associated with insulin resistance or impaired insulin secretion in Finnish subjects with normal glucose tolerance (n = 295) or impaired glucose tolerance (n = 38). These data indicate that structural variants of the IRS-2 gene were uncommon in Finnish and Chinese patients with type 2 diabetes. Thus, the variants in the coding part of the IRS-2 gene are unlikely to have a major role in the development of type 2 diabetes in Finnish or Chinese subjects.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. McGettrick, E. P. Feener, and C. R. Kahn
Human Insulin Receptor Substrate-1 (IRS-1) Polymorphism G972R Causes IRS-1 to Associate with the Insulin Receptor and Inhibit Receptor Autophosphorylation
J. Biol. Chem.,
February 25, 2005;
280(8):
6441 - 6446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Stefan, P. Kovacs, M. Stumvoll, R. L. Hanson, A. Lehn-Stefan, P. A. Permana, L. J. Baier, P. A. Tataranni, K. Silver, and C. Bogardus
Metabolic Effects of the Gly1057Asp Polymorphism in IRS-2 and Interactions With Obesity
Diabetes,
June 1, 2003;
52(6):
1544 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D'Alfonso, M. A. Marini, L. Frittitta, R. Sorge, S. Frontoni, O. Porzio, L. M. Mariani, D. Lauro, S. Gambardella, V. Trischitta, et al.
Polymorphisms of the Insulin Receptor Subtrate-2 in Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
January 1, 2003;
88(1):
317 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Akune, N. Ogata, K. Hoshi, N. Kubota, Y. Terauchi, K. Tobe, H. Takagi, Y. Azuma, T. Kadowaki, K. Nakamura, et al.
Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts
J. Cell Biol.,
October 14, 2002;
159(1):
147 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|